- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Events 238 results
Speaking Engagement
April 26, 2022
Vanessa Yen to Speak at American Conference Institute’s 17th Annual Paragraph IV Conference
Webinar
April 20, 2022
Regulation of Cell and Gene Therapies: An Overview
Speaking Engagement
April 12, 2022
David Farber, Lisa Dwyer, Adam Solander to Speak at BioDesign Israel Program
Webinar
March 30, 2022
Maximizing Contract and Treaty-Based Protections For Cross-Border Transactions in the Pharmaceutical Industry
Conference
March 21, 2022
31st Annual Health Law & Policy Forum
Speaking Engagement
March 21, 2022
Ulf Grundmann to Speak at SMi’s 16th Parallel Tade Conference
Speaking Engagement
March 17, 2022
Geneviève Michaux to Speak at Annual Conference on EU Law in the Pharmaceutical Sector 2022
Speaking Engagement
March 16, 2022
Eva Temkin, Chris Markus to Speak at Food and Drug Law Institute’s Conference About Biological Products
Webinar
February 24, 2022
Navigating the Future: Considerations Related to “Femtech” and Other Digital Health Tools
Webinar
January 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
Speaking Engagement
December 15, 2021
Eva Temkin, Elaine Tseng to Speak at AFDLI Food and Drug Law Institute Conference
Webinar
December 1, 2021
Ransomware for Healthcare Providers: What You Need To Know Right Now